MedTrace Logo

Quality Assessment in Endoscopic Retrograde Cholangiopancreatography(ERCP)

NCT02698137 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1843

Last updated 2020-04-09

No results posted yet for this study

Summary

The investigators will prospectively collect patient and procedure-related data in an observational study in order to detect patient and procedure-related risk factors for poor outcome (i.e. technical failure of the procedure; procedure-related complications).

Data will be prospectively reported using standard report forms and patients will be followed up to 30 days to detect late-onset complications.

Conditions

  • Cholangiopancreatography, Endoscopic Retrograde
  • Common Bile Duct Lithiasis
  • Biliary Strictures
  • Bile Duct and Pancreatic Tumors

Sponsors & Collaborators

  • Clinical Hospital Colentina

    lead OTHER

Principal Investigators

  • Theodor Voiosu, MD, PhD · Clinical Hospital Colentina

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-03-31
Primary Completion
2019-01-31
Completion
2019-07-31

Countries

  • Croatia
  • Italy
  • Romania

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02698137 on ClinicalTrials.gov